The Cutoff Values of Visceral Fat in Metabolic Syndrome: Evidence fromStudies

Metabolic syndrome (MetS) is associated with abdominal obesity, blood lipid disorders, inflammation, insulin resistance, diabetes, and increased risk of developing cardiovascular disease and death. Visceral fat (VF) is a risk factor for multiple CVD risk factors, including endothelial dysfunction, hypertension, dyslipidemia, diabetes, impaired glucose metabolism, insulin resistance), liver insulin resistance, non-alcoholic fatty liver disease, sleep apnea. Visceral obesity is associated with higher occurrence of cardiovascular events [1-6].